Scientific article
English

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Published inThe Lancet Infectious Diseases, vol. 18, no. 3, p. 318-327
Publication date2018
Abstract

The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity and mortality worldwide. Due to its large public health and societal implications, multidrug-resistant tuberculosis has been long regarded by WHO as a global priority for investment in new drugs. In 2016, WHO was requested by member states to create a priority list of other antibiotic-resistant bacteria to support research and development of effective drugs.

Citation (ISO format)
TACCONELLI, Evelina et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. In: The Lancet Infectious Diseases, 2018, vol. 18, n° 3, p. 318–327. doi: 10.1016/S1473-3099(17)30753-3
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1473-3099
617views
1downloads

Technical informations

Creation02/11/2018 14:42:00
First validation02/11/2018 14:42:00
Update08/10/2024 09:10:58
Status update08/10/2024 09:10:58
Last indexation31/10/2024 13:04:24
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack